As the understanding of how ATRX influences aggressivity in MYCN non-amplified neuroblastoma is similar to that found in MYCN amplified neuroblastoma,10,11 an important aspect of this will be to explore therapeutic vulnerabilities in patients with ATRX mutation and ATRX loss protein. This evidence concerns the gene ATRX and neuroblastoma.